Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs PARMAX PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM PARMAX PHARMA OMKAR PHARMACHEM/
PARMAX PHARMA
 
P/E (TTM) x 116.1 83.9 138.4% View Chart
P/BV x 2.5 2.0 121.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 OMKAR PHARMACHEM   PARMAX PHARMA
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
PARMAX PHARMA
Mar-21
OMKAR PHARMACHEM/
PARMAX PHARMA
5-Yr Chart
Click to enlarge
High Rs2152 39.8%   
Low Rs1615 104.6%   
Sales per share (Unadj.) Rs0.351.3 0.5%  
Earnings per share (Unadj.) Rs0.21.5 14.8%  
Cash flow per share (Unadj.) Rs0.25.3 4.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs8.611.4 75.3%  
Shares outstanding (eoy) m10.085.10 197.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.40.7 10,421.8%   
Avg P/E ratio x83.322.7 366.5%  
P/CF ratio (eoy) x82.96.4 1,303.8%  
Price / Book Value ratio x2.12.9 72.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m185172 107.6%   
No. of employees `000NANA-   
Total wages/salary Rs m136 4.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3262 1.0%  
Other income Rs m01 0.0%   
Total revenues Rs m3262 1.0%   
Gross profit Rs m034 0.6%  
Depreciation Rs m019 0.1%   
Interest Rs m14 16.0%   
Profit before tax Rs m012 -3.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-35 -56.6%   
Profit after tax Rs m28 29.3%  
Gross profit margin %8.113.1 61.8%  
Effective tax rate %714.737.6 1,901.6%   
Net profit margin %82.02.9 2,842.4%  
BALANCE SHEET DATA
Current assets Rs m1103 0.7%   
Current liabilities Rs m10112 8.6%   
Net working cap to sales %-332.1-3.5 9,583.7%  
Current ratio x0.10.9 8.0%  
Inventory Days Days12,5725 252,121.2%  
Debtors Days Days36523,089,062 0.0%  
Net fixed assets Rs m93112 83.1%   
Share capital Rs m10145 226.6%   
"Free" reserves Rs m-1414 -104.0%   
Net worth Rs m8758 148.9%   
Long term debt Rs m054 0.0%   
Total assets Rs m94227 41.2%  
Interest coverage x0.44.4 8.4%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x01.2 2.5%   
Return on assets %3.04.9 60.8%  
Return on equity %2.613.0 19.7%  
Return on capital %0.213.9 1.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m04 0.0%   
Net fx Rs m0-4 0.0%   
CASH FLOW
From Operations Rs m035 0.6%  
From Investments Rs mNA-31 0.0%  
From Financial Activity Rs mNA4 -4.8%  
Net Cashflow Rs m08 0.4%  

Share Holding

Indian Promoters % 0.0 30.8 0.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 69.2 144.5%  
Shareholders   3,561 1,590 224.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.